Open AccessRECENT TRENDS IN TREATMENT AND VALIDITY OF SCREENING MODELS USED IN TYPE 2 DIABETES MELLITUS: A REVIEW
Author(s) -
Ankita Tripathi,
Khushboo Bhardwaj,
Sapna Chaudhar,
Radhika Chaurasia,
Ravindra Kumar,
Shiva Raj Mishra
Publication year - 2021
Publication title -
international research journal of pharmacy
Language(s) - English
Resource type - Journals
ISSN - 2230-8407
DOI - 10.7897/2230-8407.1201110
Subject(s) - diabetes mellitus , animal model , medicine , disease , type 2 diabetes mellitus , genetically modified mouse , bioinformatics , transgene , biology , endocrinology , genetics , gene
Type II Diabetes mellitus (NIDDM) is a complex and metabolic disease that affects and presents a serious health problem for more than 100 million people around the world. Genetics and the environment are the variables which affect NIDDM. Reasonable screening models of animals will easily understand the pharmacological screening of different therapeutic agents. NIDDM animal models are acquired either naturally or caused by chemical reagents or by dietary, surgical or combination manipulation. A significant number of new genetically engineered animal models, including knock-out, transgenic, and tissue-specific knockout mice, have been designed for the Diabetes mellitus (D.M.) research in the past year. With regard to their characteristic characteristics and processes by which they arise, this analysis focuses on the animal models of NIDDM. In addition, this analysis explicitly discusses the optimal selection and use of various animal screening models for the treatment of NIDDM in preclinical research.